Efficacy Evaluation of Glimepiride in Patients With Type 2 Diabetes Mellitus and Chronic Heart Failure With Reduced Ejection Fraction.

• Status: NOT_YET_RECRUITING
• Trial end date: 2031-12-31

Summary

Evaluating the safety and efficacy of glimepiride in patients with type 2 diabetes and chronic heart failure with reduced ejection fraction--a multicenter randomized controlled study.

• Phase: PHASE3

Details

• Lead Sponsor: Tongji Hospital
• Collaborators: Anhui Provincial Hospital; Beijing Anzhen Hospital; Chinese Academy of Medical Sciences, Fuwai Hospital; First Affiliated Hospital of Xinjiang Medical University; First Hospital of China Medical University; Huaxi Hospital; Nanjing Medical University; Second Xiangya Hospital of Central South University; Shanghai Zhongshan Hospital; Southwest Medical University; The First Affiliated Hospital of Air Force Medicial University; The First Affiliated Hospital of Zhengzhou University; Tianjin Medical University; Wuhan Central Hospital; Xiangya Hospital; Zhongnan Hospital
• Treatments: glimepiride